2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Poster Session

[P61] Poster Session 61 Lung Cancer/Thoracic Cancer(ICI efficacy 2)

[P61-7] KEYNOTE-A86: Phase 3 Study of 1L Subcutaneous vs Intravenous Pembrolizumab with Platinum Chemo in Metastatic NSCLC

Takayasu Kurata1, Patrick Cobb2, Melissa L. Johnson3, Lokesh Jain4, Sung Jin Kim4, Sanatan Saraf4, Mallika Lala4, Balazs Halmos5 (1.Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan, 2.St. Vincent Frontier Cancer Center, SCL Health Research Institute, Inc., Billings, MT, USA, 3.Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, TN, USA, 4.Merck & Co., Inc., Kenilworth, NJ, USA, 5.Department of Oncology, Montefiore Einstein Center for Cancer Care, New York, NY, USA)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password